One record for
each cancer patient.

OncoGenox collects oncology reports into a single record that stays with the patient.

Request access See the platform

OncoGenox is not an EMR.

Hospitals keep the systems they already have. OncoGenox sits above them and handles the oncology side.

Existing hospital systems EMR, PACS, LIS — unchanged
ONCOGENOX
Oncology intelligence layer
Collects and organises oncology data
Connected oncology patient view One record per patient
WHY WE BUILT THIS

Cancer patient information is spread across several systems.

We built OncoGenox to bring it together.

It is developed with oncologists, medical geneticists and pharmacists, and we started with breast cancer.

One record, kept in order

Reports are kept in date order, so you see the whole history rather than the latest document.

Explore the platform →

Follow-up between visits

Patients report symptoms between appointments, and those reports sit next to the treatment they are on.

See how it works →
FIVE MODULES Structured record · Guideline context · Patient monitoring · Tumour board · Research Explore the platform →
DIVAN · VIRTUAL TUMOUR BOARD

The board meets, and the decision goes on the record.

Everyone opens the same record. What is decided is written back to the patient timeline.

DIVAN VIRTUAL TUMOUR BOARD Where decisions are made, and recorded. Medical OncologyClinical GeneticsPharmacyNursingRadiation Onc.PathologyRadiologySurgical Oncology PATIENT BC-0247 Female · 54 · Breast, left 14 source documents LONGITUDINAL RECORD The whole journey, in one view. Every specialist opens the same record — reports, results and treatment in sequence. Anatomic Stage IIB pT2 pN1a cM0 HR-positive / HER2-negative No evidence of disease current status CLINICAL TIMELINE Mar 25 Diagnosis Invasive ductal carcinoma, Grade 2 Apr 25 Staging No evidence of distant metastasis · cM0 May 25 Surgery Breast-conserving surgery · Sentinel lymph node biopsy Jun 25 Pathology 28 mm · 2/14 nodes positive · pT2 pN1a · Margins negative Nov 25 Adjuvant Chemotherapy AC → T · Completed Jan 26 Radiotherapy Completed Jun 26 Follow-Up No evidence of disease BIOMARKER PROFILE ER Positive · 95% · Strong intensity PR Positive · 80% · Moderate–strong intensity HER2 IHC 2+ · ISH non-amplified Ki-67 30% Germline BRCA1/2 No pathogenic/likely pathogenic variant detected Structured from pathology, imaging and treatment records. Access is role-based and governed by the treating institution. Illustrative record — not a real patient. Values shown for demonstration only.
Illustrative record — not a real patient.
WHO WE WORK WITH
Hospitals & Cancer Centres Works with the systems you already run. Learn more → Oncology Clinics Runs on its own, no hospital platform needed. Learn more → Pharma & Biotech Organise your own oncology data for research. Learn more → Research Institutions Build cohorts from your own patient data. Learn more →

Built in this region.

We designed it around how oncology is practised here, rather than adapting a system built elsewhere.

Bring us a case.

Send an anonymised patient journey and we'll show you how it looks in the platform.

Request access Talk to our clinical team